Elbit Systems Announces the Pricing of Underwritten Public Offering of 1,365,450 Shares
Prnewswire· 2025-05-22 00:52
Core Viewpoint - Elbit Systems Ltd. has announced a public offering of 1,365,450 ordinary shares priced at $375 per share, with gross proceeds expected to be approximately $512 million before deductions [1][2]. Group 1: Offering Details - The offering includes a 30-day option for underwriters to purchase an additional 204,817 shares at the public offering price [1]. - The offering is expected to close on May 23, 2025, subject to customary closing conditions [1]. - The shares will be listed for trading on the Nasdaq Global Select Market [1]. Group 2: Financial Information - The gross proceeds from the offering are anticipated to be around $512 million, assuming no exercise of the underwriters' option [2]. - Elbit Systems plans to use the net proceeds for general corporate purposes [2]. Group 3: Underwriters - BofA Securities, J.P. Morgan, Jefferies, and Morgan Stanley are acting as joint book-running managers for the offering [3]. - Barak Capital Underwriting is serving as a placement agent for the underwriters in Israel [3]. Group 4: Company Overview - Elbit Systems is a leading global defense technology company, employing approximately 20,000 people across five continents [6][7]. - The company reported revenues of $1.9 billion for the three months ended March 31, 2025, with an order backlog of $23.1 billion as of that date [7].
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
GlobeNewswire News Room· 2025-05-22 00:48
Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws [1][2]. Investigation Details - The investigation focuses on actions taken by CareDx insiders between April 30, 2020, and February 24, 2022, which involved issuing false and misleading statements about the company's compliance with healthcare laws and revenue growth [2]. - CareDx began disclosing issues on October 28, 2021, revealing that the company was under multiple government investigations and that its financial results were significantly lower than previously reported [2]. - By November 3, 2022, CareDx's share price had decreased by over 77.22% from its previous levels [2]. Shareholder Information - Current stockholders who have held CareDx stock since at least January 2021 are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3].
Luminar secures up to $200M following CEO departure and layoffs
TechCrunch· 2025-05-22 00:30
Core Insights - Luminar has secured a deal with Yorkville Advisors Global and another unnamed investor to raise up to $200 million through the sale of convertible preferred stock over an 18-month period [1] - The company has undergone significant leadership changes, with founder Austin Russell replaced by Paul Ricci as CEO and board chair, alongside a new round of layoffs [2] Financial Arrangement - Luminar will initially issue $35 million in convertible preferred stock, with the option to issue additional tranches of up to $35 million every 60 days at a purchase price of 96% of the stated value [3] - The proceeds from the initial issuance are intended for general corporate purposes and debt retirement, enhancing the company's financial flexibility [4] Company Background - Luminar was founded in 2012 and gained prominence during the autonomous vehicle technology boom, merging with Gores Metropoulos Inc. in 2021 at a market valuation of $3.4 billion, but currently has a market cap of $179 million [5][7] - The company has faced challenges, including multiple restructurings and a workforce reduction of about 30% in 2024, resulting in the layoff of 212 employees [8]
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
GlobeNewswire News Room· 2025-05-22 00:27
Core Viewpoint - Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. shareholders regarding alleged misconduct by certain officers and directors that may have harmed the company and its investors [1] Group 1: Legal Proceedings - The Court overseeing the securities fraud class action against Doximity denied the defendants' motion to dismiss, indicating that the plaintiffs sufficiently alleged that the defendants made materially false and/or misleading statements [1][2] - Allegations include misrepresentation of the number of active physician users on Doximity's platform and false claims of increasing user engagement, despite contrary internal data and survey evidence [2] Group 2: Company Challenges - The complaint highlights that Doximity's management touted growth prospects and revenue sustainability while downplaying challenges such as increased competition and tightening macroeconomic conditions [2] - The company is noted to rely on "upselling" advertising and services to existing clients, which may pose risks to its revenue model [2]
Solis Minerals launches maiden drill campaign at Chancho al Palo copper-gold project in Peru
Proactiveinvestors NA· 2025-05-22 00:24
Group 1 - Proactive Investors specializes in providing fast, accessible, and actionable business and finance news to a global investment audience [2][3] - The company covers a wide range of sectors including mining, energy, biotech, and emerging technologies, focusing on medium and small-cap markets as well as blue-chip companies [3] - Proactive's news team operates from key financial hubs around the world, including London, New York, Toronto, Vancouver, Sydney, and Perth [2][3] Group 2 - Proactive is committed to adopting new technologies to enhance content creation and workflow efficiency, leveraging decades of expertise [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
UnitedHealth Group Incorporated Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.
GlobeNewswire News Room· 2025-05-22 00:19
Core Viewpoint - UnitedHealth Group is facing a class action lawsuit due to a criminal investigation by the U.S. Department of Justice regarding potential Medicare fraud, which has led to significant changes in its leadership and financial guidance [3][4]. Group 1: Legal Actions and Investigations - A class action has been initiated for investors who purchased UnitedHealth securities between December 3, 2024, and April 16, 2025, with a deadline of July 7, 2025, for filing a lead plaintiff motion [1]. - The U.S. Department of Justice is conducting a criminal investigation into UnitedHealth Group concerning potential Medicare fraud, particularly focusing on the company's Medicare Advantage business practices [3]. - The investigation has reportedly been ongoing since at least the summer of 2024, although specific details of the alleged misconduct remain unclear [3]. Group 2: Corporate Developments - On May 13, 2025, UnitedHealth announced the withdrawal of its previously revised financial guidance issued on April 17, indicating potential financial instability [4]. - Following the announcement, CEO Andrew Witty has stepped down, with Chairman Stephen Hemsley taking over as the new CEO [4].
Microsoft files legal action against information-stealing malware Lumma Stealer
New York Post· 2025-05-22 00:07
Core Insights - Microsoft has filed legal action against Lumma Stealer after discovering nearly 400,000 Windows computers infected by the malware globally in the past two months [1][3] - Lumma Stealer is capable of stealing data from various browsers and applications, including cryptocurrency wallets, and can install additional malware [1] - The U.S. Department of Justice has seized five internet domains used by cybercriminals to operate the LummaC2 malware service, with the FBI investigating the case [4] Company Actions - Microsoft's Digital Crimes Unit (DCU) played a crucial role in the takedown, suspension, and blocking of malicious domains that supported Lumma's infrastructure through a court order from the U.S. District Court of the Northern District of Georgia [3] - The company emphasizes the need for layered defenses and industry collaboration to combat the evolving threats posed by cybercrime, as highlighted by the growth and resilience of Lumma Stealer [4]
ECG ALERT: Kirby McInerney LLP Reminds Everus Construction Group, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
GlobeNewswire News Room· 2025-05-22 00:00
Core Viewpoint - A federal securities class action has been filed on behalf of investors in Everus Construction Group, Inc. due to undisclosed issues regarding the company's backlog conversion cycle and revenue recognition delays [1][5]. Company Overview - Everus Construction Group, Inc. was formerly known as MDU Construction Services Group, Inc. and operated as a wholly owned subsidiary of CEHI, LLC, which is a subsidiary of MDU Resources [3]. Financial Performance - On February 11, 2025, Everus reported its fourth quarter and full year 2024 financial results, projecting revenue between $3.0 billion and $3.1 billion and EBITDA between $210 million and $225 million for 2025 [4]. - Following the financial results announcement, Everus shares fell by $12.43, approximately 18%, from $68.42 to $55.99 [4]. Class Action Details - The class action is focused on the period from October 31, 2024, to February 11, 2025, and includes investors who held MDU Resources common stock as of October 21, 2024, and acquired Everus common stock during the spinoff [1]. - The complaint alleges that the company failed to disclose the elongation of its backlog conversion cycle and the resulting delays in revenue recognition [5].
Kirby McInerney LLP Reminds Digimarc Corporation (DMRC) Investors of Class Action Filing and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-22 00:00
Core Points - A class action lawsuit has been filed against Digimarc Corporation for securities fraud, affecting investors who purchased shares between May 3, 2024, and February 26, 2025 [3][5] - The lawsuit alleges that Digimarc failed to disclose critical information regarding a significant commercial partner's contract renewal, which negatively impacted the company's revenue [5] Financial Performance - For Q4 2024, Digimarc reported a 10% decline in quarterly subscription revenue, falling to $5.0 million from $5.6 million year-over-year [4] - Annual recurring revenue decreased to $20.0 million from $22.23 million in the previous year, primarily due to a $5.8 million drop in ARR linked to the expiration of a commercial contract in June 2024 [4] - Following the financial announcement, Digimarc's share price plummeted by $11.65, approximately 43%, closing at $15.39 on February 27, 2025 [4]
A Closer Look at Retail Earnings
ZACKS· 2025-05-21 23:45
Retail Sector Performance - Target has consistently underperformed, failing to meet even lowered estimates, indicating ongoing challenges in the post-COVID environment and losing market share to Walmart and Amazon [3][4] - Walmart continues to thrive, leveraging its digital business to enhance sales of essential goods and expand into high-margin areas such as advertising and third-party marketplaces [4][5] - The disparity in revenue sources is notable, with approximately 60% of Walmart's revenue coming from essentials compared to only 20% for Target, impacting their respective performances [5][6] Earnings Trends - For Q1, total earnings for 469 S&P 500 members increased by 11.5% year-over-year, with revenues up by 4.3%, but the percentage of companies beating EPS and revenue estimates fell below historical averages [8] - In the Retail sector, earnings rose by 11.5% with a 5% increase in revenues, but excluding Amazon, the growth rate drops to a decline of 5.2% [8] Future Expectations - Q2 earnings for the S&P 500 are projected to grow by 5.5% year-over-year, with revenues expected to rise by 3.8%, although estimates have been cut across most sectors [10][11] - The Tech sector is expected to see earnings growth of 12.1% in Q2, but this is a reduction from earlier projections, indicating a stabilization in revisions [14][16]